UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K




CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report:  April 26, 2011

(Date of earliest event reported)

 




BIO-RAD LABORATORIES, INC.

(Exact name of registrant as specified in its charter)

 




Commission File Number: 1-7928

 

 

 

 

Delaware

 

94-1381833

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)


 

1000 Alfred Nobel Dr.

Hercules, California 94547

(Address of principal executive offices, including zip code)

 

(510) 724-7000

(Registrant’s telephone number, including area code)

 





Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


 

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


 

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


 

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))






 


ITEM 5.07

Submission of Matters to a Vote of Security Holders.


Bio-Rad Laboratories, Inc. (the Company) held its Annual Meeting of Stockholders on April 26, 2011.   The matters voted upon at the meeting and the results of those votes were as follows:


1. Election of Directors.

 

 

 

 

 

 

 

Class of

 

 

 

 

 

Common Stock

Votes

Votes

Votes

Broker

 

to Elect

For

Withheld

Abstaining

Non-Votes

 

 

 

 

 

 

Louis Drapeau

Class A

16,802,118

2,629,194

-

1,757,204

Albert J. Hillman

Class A

16,729,654

2,701,658

-

1,757,204

Dr. Ted W. Love

Class B

4,824,229

30,850

-

210,365

Alice N. Schwartz

Class B

4,817,557

37,522

-

210,365

David Schwartz

Class B

4,817,557

37,522

-

210,365

Norman Schwartz

Class B

4,818,613

36,466

-

210,365

 

 

2. Ratification of the selection of Ernst & Young LLP as the Company’s independent auditors for the fiscal year ending December 31, 2011.

 

Votes

Votes

Votes

Broker

For

Against

Abstaining

Non-Votes

7,151,437

1,495

31,364

-

 

 

 

 

 

 

 

 

  3. Approval of the Bio-Rad Laboratories, Inc. 2011 Employee Stock Purchase Plan.

 

 

 

 

Votes

Votes

Votes

Broker

For

Against

Abstaining

Non-Votes

6,731,675

48,155

18,381

386,085

 

 

 

 

 

 

 

 

 

 

 

 

  4. Advisory vote on executive compensation.

 

 

 

 

Votes

Votes

Votes

Broker

For

Against

Abstaining

Non-Votes

6,716,867

77,542

3,802

386,085

 

 

 

 

 

 

 

 

 

 

 

 

  5. Advisory vote on the frequency of executive compensation votes.

 

 

 

 

Votes

Votes

Votes

Votes

1 year

2 years

3 years

Abstaining

1,042,159

60,901

5,690,841

4,310

 

 

 

 

 

 

 

 

 

 

 

 

In light of these voting results, the Company will include the advisory vote on executive compensation in its proxy materials every 3 years until the next required vote on the frequency of such advisory votes.







SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  

 

 

 

 

 

 

 

 

 

 

 

 

 

BIO-RAD LABORATORIES, INC.

 

 

 

 

 

Date:

May 2, 2011

 

By:

/s/ Christine A. Tsingos

 

 

 

 

 

Christine A. Tsingos

 

 

 

 

 

Vice President, Chief Financial Officer